Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.24 USD | +1.82% | -10.04% | -29.56% |
06-04 | Lumos Pharma, Inc. Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024 | CI |
05-15 | Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA | CI |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
LUMOS PHARMA, INC. | Other Biotechnology & Medical Research | +1.82% | -10.04% | -29.56% | -47.17% | - | 17.86M |
- Stock Market
- Equities
- LUMO Stock
- Charts Lumos Pharma, Inc.
- Relative Strength Chart